TY  - JOUR

T1  - The cancer therapeutic potential of <scp>Chk1</scp> inhibitors: how mechanistic studies impact on clinical trial design

JO  - British Journal of Clinical Pharmacology

UR  - http://dx.doi.org/10.1111/bcp.12139

PY  - 2013/08/20

AU  - Thompson R

AU  - Eastman A

ED  - 

DO  - DOI: 10.1111/bcp.12139

PB  - Wiley

VL  - 76

IS  - 3

SP  - 358

EP  - 369

Y2  - 2024/09/19

ER  -